Reviewer Policies

  1. Conflict of Interest and Financial Disclosures (specific to reviewers)
  2. Reviewers Guidelines
  1. Conflict of Interest and Financial Disclosures (Specific to Reviewers)

The Indo-American Journal of Pharma and Bio Sciences (IAJPBS) upholds the highest standards of transparency and integrity in the peer review process. A core aspect of maintaining this integrity is ensuring that reviewers disclose any conflicts of interest (COI) that may compromise their impartiality during the review process. A conflict of interest occurs when a reviewer’s personal, financial, or professional relationships could influence their objectivity in evaluating a manuscript.

All potential reviewers are required to disclose any financial relationships, affiliations, or associations that may present a conflict of interest. These may include, but are not limited to, financial interests in companies or institutions that could benefit from the research findings, professional collaborations with the authors, or personal relationships that could bias their review. In cases where reviewers are involved in the same research project or have any other relationship with the authors that may lead to bias, it is essential that they recuse themselves from the review process for that particular manuscript.

Reviewers must also disclose any funding sources that may impact the evaluation of the manuscript. This includes sponsorship from organizations or companies that may have vested interests in the publication of the article, especially in the pharmaceutical and biosciences fields. If a reviewer has any potential conflicts, they must notify the editorial team before accepting the invitation to review. In cases where a conflict is identified during the review process, the editor may assign an alternative reviewer, or the manuscript may be rejected.

The IAJPBS ensures that all disclosures of conflicts of interest are taken seriously and that proper steps are taken to mitigate any undue influence. This adherence to ethical guidelines ensures that the peer review process is fair, transparent, and unbiased, which is critical to maintaining the journal's academic credibility and trustworthiness.

  1. Reviewers Guidelines

The Indo-American Journal of Pharma and Bio Sciences (IAJPBS) values the contributions of its reviewers, recognizing that their expertise and critical feedback are essential to maintaining the high standards of scientific publishing. To ensure consistency, fairness, and the integrity of the peer review process, the journal provides comprehensive guidelines for reviewers.

Reviewers are expected to assess manuscripts based on their scientific merit, originality, relevance, clarity, and methodological rigor. They should evaluate the validity of the research findings, the quality of the data analysis, and whether the conclusions are supported by the data. Reviewers must also examine the manuscript for its compliance with ethical standards, particularly regarding the handling of human or animal subjects, data integrity, and proper citations of previous work.

One of the key expectations for IAJPBS reviewers is maintaining confidentiality. Reviewers must not share or discuss the manuscript with others during the review process. They are also prohibited from using any information gained through the review for personal gain or to influence the field inappropriately. All manuscripts are confidential until they are officially published, and reviewers must respect this confidentiality throughout the review process.

Reviewers are also encouraged to provide constructive feedback to authors, offering suggestions for improvements while being respectful and professional in their communication. If a reviewer identifies significant issues such as plagiarism, data manipulation, or other ethical concerns, these must be reported immediately to the editorial team, who will follow the appropriate procedures in line with publication ethics.

Reviewers should declare any conflicts of interest (as outlined in the previous policy) before agreeing to review a manuscript, ensuring that their evaluation remains objective and unbiased. They should assess the manuscript independently and provide their recommendation for publication: accept, minor revisions, major revisions, or reject.

By adhering to these guidelines, reviewers help maintain the journal's reputation for high-quality, rigorous, and ethical scientific publishing. The IAJPBS deeply appreciates the time and expertise that reviewers contribute to the journal and ensures that their efforts are integral to the advancement of knowledge in pharmaceutical and biosciences fields.